All the news Showing 10 of 938 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Therapies Interferon-lambda as effective as alpha but with much better safety profile in hepatitis C Michael Carter / 20 April 2012 A new form of pegylated interferon is associated with significantly fewer side-effects than the standard form of the drug, a study conducted in patients with the easier-to-treat hepatitis C genotypes shows. Data from ... Transmission, epidemiology and prevention Hepatitis C infection now twice as common in HIV+ gay men as injecting drug users, Swiss study finds Gus Cairns / 06 April 2012 Twice as many HIV-positive gay men are now being infected with hepatitis C as HIV-positive injecting drug users, a Swiss study presented to the 19th Retrovirus Conference has found.New hepatitis ... Access to medicines & diagnostics Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings Michael Carter / 27 March 2012 The rollout of antiretroviral therapy in resource-limited settings provides a model for efforts to increase access to hepatitis C treatment and care in similar settings, investigators argue in the online edition of Clinical ... Treatment issues Studies look at interactions between new hepatitis C drugs and HIV antiretrovirals Liz Highleyman / 14 March 2012 Drug-drug interactions between direct-acting antiviral agents for hepatitis C and some antiretroviral medications used to treat HIV are common, but are often modest and can be managed with dose adjustments when treating people ... Treatment issues GS-7977 plus ribavirin rapidly suppresses HCV but most patients relapse Liz Highleyman / 07 March 2012 An interferon-free combination of the experimental polymerase inhibitor GS-7977 plus ribavirin potently and rapidly reduced hepatitis C virus (HCV) levels, but almost all patients experienced viral rebound after they stopped treatment, researchers reported ... Treatment issues Telaprevir and boceprevir boost sustained response rates for HIV/HCV coinfected Liz Highleyman / 07 March 2012 Adding a first-generation hepatitis C virus (HCV) protease inhibitor to pegylated interferon/ribavirin dramatically increases the likelihood of 12-week sustained virological response to hepatitis C treatment among HIV/HCV coinfected people, researchers reported on Tuesday at ... Treatment issues Hepatitis C subtype-1b and carriage of IL28B gene associated with improved treatment responses in HIV-co-infected patients Michael Carter / 01 March 2012 Hepatitis C treatment responses in patients co-infected with HIV are better in patients infected with hepatitis C subtype-1b than 1a, according to Spanish research published in the online edition of the ... Treatment issues Hepatitis C protease inhibitor therapy cost-effective in some circumstances Michael Carter / 21 February 2012 First-line hepatitis C therapy which includes a protease inhibitor can be cost-effective, investigators show in the Annals of Internal Medicine. The study showed that a triple combination of drugs, including the cheaper ... Epidemiology Hepatitis C surpasses HIV as a cause of death in the US Michael Carter / 21 February 2012 Deaths in the US due to hepatitis C now exceed those caused by HIV, according to research published in the Annals of Internal Medicine. The study showed that there is a ... Professional tattooing in sterile environment not associated with risk of hepatitis C Michael Carter / 08 February 2012 Tattooing or body piercing in professional parlours is not associated with an increased risk of infection with hepatitis C virus, a literature review published in the online edition of Clinical Infectious Diseases shows. However, ... ← Prev1...8889909192...94Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive